| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 02/09/2006 | WO2006015057A2 C-terminally truncated interferon |
| 02/09/2006 | WO2006015045A2 Methods and compositions for modulating flowering and maturity in plants |
| 02/09/2006 | WO2006014816A2 Canis sphingosine 1-phosphate receptor isoform 2 |
| 02/09/2006 | WO2006014802A2 Canis sphingosine 1-phosphate receptor isoform 1 |
| 02/09/2006 | WO2006014678A2 Compositions and methods of using angiopoietin-like 4 protein |
| 02/09/2006 | WO2006014540A2 Plant n-acylethanolamine binding proteins |
| 02/09/2006 | WO2006014493A2 Mechanically activated channel blocker |
| 02/09/2006 | WO2006014468A2 Saif, an anti-inflammatory factor, and methods of use thereof |
| 02/09/2006 | WO2006014349A2 Method of producing fully carbamylated erythropoietin |
| 02/09/2006 | WO2006014316A1 Antifungal polypeptides |
| 02/09/2006 | WO2006014253A2 Factor viia variants |
| 02/09/2006 | WO2006013807A1 Arabinogalactan protein having activity of improving tolerance to heat or moisture stress |
| 02/09/2006 | WO2006013610A1 Shigella mutants in the functions pertaining to the processes of maturing and recycling peptidoglycans and their uses as immunogens |
| 02/09/2006 | WO2006013552A2 Articles of peptide nanostructures and method of forming the same |
| 02/09/2006 | WO2006013468A2 Polypeptide |
| 02/09/2006 | WO2006013462A2 Growth factors nsg28, nsg30, and nsg32 |
| 02/09/2006 | WO2006013388A2 Materials and methods for modulating signalling by alpha-v integrin molecules |
| 02/09/2006 | WO2006013336A1 Hpv vaccine comprising peptides from host cell proteins |
| 02/09/2006 | WO2006013334A1 Hai-1 and hai-2 in cancer therapy |
| 02/09/2006 | WO2006013202A2 Conjugation of fvii |
| 02/09/2006 | WO2006013106A2 Vaccine for prevention and treatment of hiv-infection |
| 02/09/2006 | WO2006013014A2 Diagnostics and therapeutics for diseases associated with prostate-specific membrane antigen-like protein (psmal) |
| 02/09/2006 | WO2006013010A2 Preparation of organisms with faster growth and/or higher yield |
| 02/09/2006 | WO2005123778A3 Soluble zcytor14, anti-zcytor14 antibodies and binding partners and methods of using in inflammation |
| 02/09/2006 | WO2005123771A3 Oligomeric peptides and their use for the treatment of hiv infections |
| 02/09/2006 | WO2005120565A8 Sars vaccines and methods to produce highly potent antibodies |
| 02/09/2006 | WO2005118864A3 Antibodies and related molecules that bind to psca proteins |
| 02/09/2006 | WO2005110479A3 Treatments for pancreatic cancer |
| 02/09/2006 | WO2005108617A3 Mutant receptors and their use in a nuclear receptor-based inducible gene expression system |
| 02/09/2006 | WO2005103302A3 Mutant viral nucleic acids and vaccine containing same |
| 02/09/2006 | WO2005098037A8 Breast cancer signatures |
| 02/09/2006 | WO2005093425A3 Diagnostics and therapeutics for diseases associated with g-protein coupled receptor 58 (gpr58) |
| 02/09/2006 | WO2005093423A3 Diagnostics and therapeutics for diseases associated with peroxisome proliferative activated receptor alpha (ppara) |
| 02/09/2006 | WO2005089789A3 Y2 selective receptor agonists for therapeutic interventions |
| 02/09/2006 | WO2005086800A3 Cell-penetrating socs polypeptides that inhibit cytokine-induced signaling |
| 02/09/2006 | WO2005074647A3 Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same |
| 02/09/2006 | WO2005072403A3 Bone morphogenic protein binding peptide |
| 02/09/2006 | WO2005027825A3 Recombinant parainfluenza virus expression systems and vaccines comprising heterologous antigens derived from metapneumovirus |
| 02/09/2006 | WO2005017188A3 Fusion proteins with a membrane translocating sequence and methods of using same to inhibit an immune response |
| 02/09/2006 | WO2005016953A3 Antagonistic analogs of gh-rh (2003) |
| 02/09/2006 | WO2005010038A3 Peptide protein translation inhibitor and the use thereof for protein translation control |
| 02/09/2006 | WO2004113517A3 IMPROVED METHOD FOR THE RECOVERY OF NON-SEGMENTED, NEGATIVE-STRANDED RNA VIRUSES FROM cDNA |
| 02/09/2006 | WO2004028478A3 Functional mutations in respiratory syncytial virus |
| 02/09/2006 | WO2004022580A3 Bh3 peptides and method of use thereof |
| 02/09/2006 | WO2004009616A3 Ghrelin analogs |
| 02/09/2006 | WO2004002415A3 Compositions and methods for modulating a cytotoxic t lymphocyte immune response |
| 02/09/2006 | WO2003100027A3 Mutant fibronectin and tumor metastasis |
| 02/09/2006 | WO2002097110A3 TUMOR ENDOTHELIAL MARKER 7α MOLECULES AND USES THEREOF |
| 02/09/2006 | WO2002088316A3 G-protein coupled receptors |
| 02/09/2006 | US20060031968 Isolated plant deoxyhypusine synthase and nucleotides encoding same |
| 02/09/2006 | US20060031967 Compositions and methods for modulation of plant cell division |
| 02/09/2006 | US20060031962 Antifungal polypeptides |
| 02/09/2006 | US20060031960 Sequence-determined DNA encoding AP2 domain polypeptides |
| 02/09/2006 | US20060031959 Nucleic acid fragments encoding proteins involved in stress response |
| 02/09/2006 | US20060031956 Nucleotide sequences for gene regulation and methods of use thereof |
| 02/09/2006 | US20060031954 FcRn-based therapeutics for the treatment of auto-immune disorders |
| 02/09/2006 | US20060031950 Non-mammalian transgenic animal model for cellular proliferative diseases |
| 02/09/2006 | US20060031944 Embryonic stem cells capable of differentiating into desired cell lines |
| 02/09/2006 | US20060030695 Platelet-derived growth factor-D; anticarcinogenic agents, angiogenesis inhibition; tissue-targeted therapy; immunoassays; cancer diagnosis |
| 02/09/2006 | US20060030694 Antitumor agents; fusion protien increases biological half life |
| 02/09/2006 | US20060030530 Methods of screening for compounds that modulate the LSR-leptin interaction and their use in the prevention and treatment of obesity-related diseases |
| 02/09/2006 | US20060030529 Use of VEGF inhibitors for treatment of eye disorders |
| 02/09/2006 | US20060030527 Rage fusion proteins and methods of use |
| 02/09/2006 | US20060030525 Apolipoprotein A-I derivatives with altered immunogenicity |
| 02/09/2006 | US20060030524 Treatment of systemic lupus erythematosus by down-regulating the autoimmune response to autoantigens |
| 02/09/2006 | US20060030522 ALK7 and myostatin inhibitors and uses thereof |
| 02/09/2006 | US20060030521 Remodeling and glycoconjugation of peptides |
| 02/09/2006 | US20060030518 Acylated insulin |
| 02/09/2006 | US20060030048 Plasmid maintenance system for antigen delivery |
| 02/09/2006 | US20060030047 Plasmid maintenance system for antigen delivery |
| 02/09/2006 | US20060030046 Polypeptide of given sequence; improved efficiency by using heparin binding domain derived from fibronectin; replication deficient vector |
| 02/09/2006 | US20060030011 Polynucleotides encoding polypeptides involved in the stress response to environmental changes in Methylophilus methylotrophus |
| 02/09/2006 | US20060030010 Polynucleotides encoding polypeptides involved in intermediates metabolism of central metabolic pathway in Methylophilus methylotrophus |
| 02/09/2006 | US20060030008 kit for purifying a recombinant fusion protein containing a DNA expression vector plasmid having a sequence encoding a mutant chitin-binding domain capable of reversible binding under non-denaturing conditions |
| 02/09/2006 | US20060030007 Peptides for metal ion affinity chromatography |
| 02/09/2006 | US20060030006 Identification of a conserved region of plasmodium falciparum MSP3 targeted by biologically active antibodies |
| 02/09/2006 | US20060030005 C3b/C4b complement receptor-like molecules and uses thereof |
| 02/09/2006 | US20060030004 Solid phase synthesis |
| 02/09/2006 | US20060030002 Isoforms of the human Vitamin D receptor |
| 02/09/2006 | US20060030000 Growth factor binding constructs materials and methods |
| 02/09/2006 | US20060029999 Nucleic acid sequences having an activity of regulating translation efficiency and utilization thereof |
| 02/09/2006 | US20060029998 Codes with nucleic acids; antiinflammatory agents; immunomodulation |
| 02/09/2006 | US20060029997 nucleic acid sequence encoding an adhesive protein derived from a mollusk foot protein(MEFP-1); waterproof adhesives |
| 02/09/2006 | US20060029996 CDNA, or expression vector comprising the nucleotide sequence linked to an expression control sequence; biosynthesis of waterproof bioadhesive proteins, adhesins; high strength, durability |
| 02/09/2006 | US20060029990 Method for diagnosing inflammatory diseases and infections by the determination of lasp-1 immunoreactivity |
| 02/09/2006 | US20060029986 Prevention and treatment of cardiovascular pathologies |
| 02/09/2006 | US20060029984 PSP94 diagnostic reagents and assays |
| 02/09/2006 | US20060029983 Methods of screening compounds for GRK6 modulating activity |
| 02/09/2006 | US20060029981 monoclonal antibody which specifically binds to an amino acid sequence of islet neogenesis associated protein (INGAP), used in competitive binding assays for quantitation of INGAP in biological samples |
| 02/09/2006 | US20060029966 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/09/2006 | US20060029964 Eating disorders; measuring obesity receptor (ObR) gene expression by detecting mRNA transcripts |
| 02/09/2006 | US20060029963 Isolated from Bacillus substilus; solid phase synthesis; reverse transcription; immunogens; transfected cells |
| 02/09/2006 | US20060029947 Combinatorial protein library screening by periplasmic expression |
| 02/09/2006 | US20060029945 Novel full length cDNA |
| 02/09/2006 | US20060029944 Identification of polynucleotides for predicting activity of compounds that interact with and/or modulate protein tyrosine kinases and/or protein tyrosine kinase pathways in breast cells |
| 02/09/2006 | US20060029940 Prostate stem cell antigen (PSCA) variants and subsequences thereof |
| 02/09/2006 | US20060029931 Small, interfering RNA (siRNA) molecules which inhibit expression of HALP (HIV-Associated Life Preserver) protein cloned into a plasmid or retroviral vector for introduction into host cells; screening HIV-modulating componds which prevent apoptosis resistance of infected cell; gene therapy |
| 02/09/2006 | US20060029928 Polynucleic acids isolated from a porcine reproductive and respiratory syndrome virus (prrsv), proteins encoded by the polynucleic acids, vaccines based on the proteins and/or polynucleic acids, a method of protecting a pig from a prrsv and a method of detecting a |
| 02/09/2006 | US20060029638 Methods for treating body tissue |
| 02/09/2006 | US20060029621 Vaccines for broad spectrum protection against diseases caused by Neisseria meningitidis |